Navigation Links
Andrew Technologies Names Tom Albright CEO and Board Member

NEW YORK, June 20, 2011 /PRNewswire/ -- Andrew Technologies, LLC the maker of a new, suction-assisted liposuction system has named Tom Albright as Chief Executive Officer and Board Member.

Mr. Albright joins Andrew Technologies with almost 3 decades of drug, biologic, device and aesthetic-related sales, marketing, and general management experience. He has held leadership positions at Allergan (the world's leading aesthetic medical company), Nobel Biocare (the world's leading aesthetic dental company) and most recently was the President and General Manager of the Topical Aesthetic division at Syneron (the world's leading energy-based aesthetic device company). Mr. Albright began his healthcare career at Parke-Davis, and was a marketing director on the launch team of Lipitor® (the world's best-selling pharmaceutical product) and other popular brands.

Among the most noted accomplishments in his 11 years in aesthetic healthcare, Mr. Albright's experience includes: global leadership of the landmark BOTOX® Cosmetic launch, commercial lead for the development of Latisse®, North American leadership of the NobelActive® launch, and Global leadership of the elure™ launch at Syneron.

Mr. Albright has a BS in Biology from The Citadel and an MBA in Marketing from Mercer University.

"Our adipose-selective technology provides benefits for physicians and patients seeking aesthetic body contouring. We are thrilled to have Tom's leadership at Andrew Technologies, his extensive expertise in commercializing innovative medical aesthetics solutions offers a significant competitive advantage to our company," said Dr. Mark Andrew, Chief Scientific Officer of Andrew Technologies.

Bill Doyle, Managing Partner of WFD Ventures, stated,  "Andrew Technologies is poised to provide high quality aesthetic body contouring to both patients and surgeons; and we are excited about working with Tom to assist the Company in executing its growth plan."

About Andrew Technologies, LLC

Andrew Technologies is a venture capital funded medical device company that will be based in Orange County, CA and is focused on the future launch of an FDA-cleared, adipose-selective lipoplasty system. The selective tissue liquefaction concept of this new lipoplasty system is based on the patented AquaLase® surgical modality of the Infiniti™ Vision System (the world's leading cataract surgical system) sold by Alcon Inc. (ACL). Dr. Mark Andrew is the co-inventor of both applications.

About WFD Ventures

WFD Ventures is a New York based venture capital firm investing in medical device companies with exceptional potentials. In addition to capital, WFD provides product development, regulatory and commercialization guidance to its portfolio companies. For more information, visit .

SOURCE Andrew Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mr. Robert Andrews Joins Asymchem Life Science (Tianjin) Co. Ltd. as Vice President of Quality Assurance
2. BrainScope® Announces Appointment of Professor Peter Andrews, MD to Its Medical Advisory Board
3. St. Andrews Country Club of Boca Raton Members Team Up With Morgan Pressel to Raise $405,000 to Fight Breast Cancer
4. Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
5. ClinOps, LLC Enhances Senior Management Team With Addition of Connie Andrews as Senior Vice President of Clinical Operations
6. BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase Program
7. Reportlinker Adds Top Medical Devices and Imaging Technologies 2011
8. Hotspur Technologies Appoints Fred Khosravi Chairman of the Board
9. China Medical Technologies Announces the Purchase of its ADSs by Chengxuan in the Open Market
10. Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
11. Aethlon Medical to Discuss Recent Progress at the LHA Life Sciences & Medical Technologies Virtual Conference on June 16
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):